Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Cardiovascular and noncardiovascular mortality among men and women starting dialysis.

Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1722-30. doi: 10.2215/CJN.11331210.

2.

Cardiovascular and noncardiovascular mortality among patients starting dialysis.

de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW.

JAMA. 2009 Oct 28;302(16):1782-9. doi: 10.1001/jama.2009.1488.

PMID:
19861670
3.

[Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].

Rufino JM, García C, Vega N, Macía M, Hernández D, Rodríguez A, Maceira B, Lorenzo V.

Nefrologia. 2011;31(2):174-84. doi: 10.3265/Nefrologia.pre2011.Jan.10743. Spanish.

4.

Survival in patients treated by long-term dialysis compared with the general population.

Nordio M, Limido A, Maggiore U, Nichelatti M, Postorino M, Quintaliani G; Italian Dialysis and Transplantation Registry.

Am J Kidney Dis. 2012 Jun;59(6):819-28. doi: 10.1053/j.ajkd.2011.12.023. Epub 2012 Feb 22.

PMID:
22361043
5.

Bone alkaline phosphatase and mortality in dialysis patients.

Drechsler C, Verduijn M, Pilz S, Krediet RT, Dekker FW, Wanner C, Ketteler M, Boeschoten EW, Brandenburg V; NECOSAD Study Group.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1752-9. doi: 10.2215/CJN.10091110. Epub 2011 May 19.

6.

Kidney function as a predictor of noncardiovascular mortality.

Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB.

J Am Soc Nephrol. 2005 Dec;16(12):3728-35. Epub 2005 Oct 26.

7.

Is there any survival advantage of obesity in Southern European haemodialysis patients?

Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D.

Nephrol Dial Transplant. 2009 Sep;24(9):2871-6. doi: 10.1093/ndt/gfp168. Epub 2009 Apr 15.

8.

Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.

Brunner FP, Brynger H, Challah S, Fassbinder W, Geerlings W, Selwood NH, Tufveson G, Wing AJ.

Nephrol Dial Transplant. 1988;3(5):585-95.

PMID:
3146713
9.

Survival trends of US dialysis patients with heart failure: 1995 to 2005.

Stack AG, Mohammed A, Hanley A, Mutwali A, Nguyen H.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1982-9. doi: 10.2215/CJN.01130211. Epub 2011 Jul 22.

10.

Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study.

Thong MS, Kaptein AA, Benyamini Y, Krediet RT, Boeschoten EW, Dekker FW; Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group.

Am J Kidney Dis. 2008 Jul;52(1):111-7. doi: 10.1053/j.ajkd.2008.04.001. Epub 2008 May 29.

PMID:
18511166
11.

UK Renal Registry 13th Annual Report (December 2010): Chapter 6: survival and causes of death of UK adult patients on renal replacement therapy in 2009: national and centre-specific analyses.

Castledine C, Steenkamp R, Feest T, Tomson CR.

Nephron Clin Pract. 2011;119 Suppl 2:c107-34. doi: 10.1159/000331756. Epub 2011 Aug 26.

PMID:
21894029
12.

Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe.

van de Luijtgaarden MW, Noordzij M, Stel VS, Ravani P, Jarraya F, Collart F, Schön S, Leivestad T, Puttinger H, Wanner C, Jager KJ.

Nephrol Dial Transplant. 2011 Sep;26(9):2940-7. doi: 10.1093/ndt/gfq845. Epub 2011 Feb 16.

13.

Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes.

Hu G; DECODE Study Group.

Diabetologia. 2003 May;46(5):608-17. Epub 2003 May 15.

PMID:
12750769
14.

Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.

Vogelzang JL, van Stralen KJ, Noordzij M, Diez JA, Carrero JJ, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hoitsma A, Leivestad T, de Meester J, Metcalfe W, Palsson R, Postorino M, Ravani P, Vanholder R, Wallner M, Wanner C, Groothoff JW, Jager KJ.

Nephrol Dial Transplant. 2015 Jun;30(6):1028-37. doi: 10.1093/ndt/gfv007. Epub 2015 Jan 29.

PMID:
25637641
15.

Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada.

Rabbat CG, Thorpe KE, Russell JD, Churchill DN.

J Am Soc Nephrol. 2000 May;11(5):917-22.

16.
17.

Increased risk of fatal infections in women starting peritoneal dialysis.

Ros S, Remón C, Qureshi AR, Quiros P, Lindholm B, Carrero JJ.

Perit Dial Int. 2013 Sep-Oct;33(5):487-94. doi: 10.3747/pdi.2012.00243. Epub 2013 Oct 1.

18.

UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses.

Ansell D, Roderick P, Hodsman A, Ford D, Steenkamp R, Tomson C.

Nephron Clin Pract. 2009;111 Suppl 1:c113-39. doi: 10.1159/000209996. Epub 2009 Mar 26.

PMID:
19542694
19.
20.

Long-term modality-related mortality analysis in incident dialysis patients.

Lee CC, Sun CY, Wu MS.

Perit Dial Int. 2009 Mar-Apr;29(2):182-90.

Items per page

Supplemental Content

Write to the Help Desk